Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Infectious Diseases

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/651611PMID 20350164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.

  2008cited by this paper
• Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

  2008cited by this paper
• Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.

  2007cited by this paper
• Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico.

  2007cited by this paper
• An Introduction to the Bootstrap

  2007cited by this paper
• Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.

  2007cited by this paper
• Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.

  2007cited by this paper
• Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba

  2007cited by this paper
• Development of inactivated poliovirus vaccine derived from Sabin strains.

  2006cited by this paper
• Technology transfer of Sabin-IPV to new developing country markets.

  2006cited by this paper
• Risk Management in a Polio‐Free World

  2006cited by this paper
• Technology evaluation: TroVax, Oxford BioMedica.

  2004cited by this paper
• Serum antibody responses after intradermal vaccination against influenza.

  2004cited by this paper
• Dose sparing with intradermal injection of influenza vaccine.

  2004cited by this paper
• Progress towards poliomyelitis eradication in India, 2002.

  2003cited by this paper
• Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.

  2002cited by this paper
• "Endgame" issues for the global polio eradication initiative.

  2002cited by this paper
• Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

  2001cited by this paper
• Apparent global interruption of wild poliovirus type 2 transmission.

  2001cited by this paper
• Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication.

  2001cited by this paper
• Age‐ and dose‐interval‐dependent antibody responses to inactivated poliovirus vaccine

  2001cited by this paper
• Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine.

  1998cited by this paper
• The polio eradication effort: should vaccine eradication be next?

  1997cited by this paper
• The skin as an organ of immunity.

  1997cited by this paper
• Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.

  1997cited by this paper
• The skin as an organ of immunity

  1997cited by this paper
• Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.

  1996cited by this paper
• Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval.

  1995cited by this paper
• Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.

  1994cited by this paper
• Immune response of infants to inactivated poliovirus vaccine injected intradermally.

  1992cited by this paper
• Low-dose intradermal and intramuscular vaccination against hepatitis B.

  1992cited by this paper
• Immune response to intradermally injected inactivated poliovirus vaccine.

  1991cited by this paper
• Global eradication of poliomyelitis by the year 2000.

  1988cited by this paper
• Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.

  1987cited by this paper
• Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency.

  1985cited by this paper
• Practical Nonparametric Statistics

  1972cited by this paper
• Antibody response to poliomyelitis vaccine administered by jet injection.

  1958cited by this paper
• Mass inoculation of the Salk polio vaccine with the multiple dose jet injector.

  1957cited by this paper
• Mass inoculation of the Salk polio vaccine with the multiple dose jet injector.

  1957cited by this paper
• Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.

  1953cited by this paper
• STUDIES in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.

  1953cited by this paper
• Recent studies on immunization against poliomyelitis.

  1953cited by this paper

• Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

  2025cites this paper
• Estimation of the poliovirus type 2 immunity gap in South Africa

  2024cites this paper
• Microneedle-mediated drug delivery for neurological diseases.

  2024cites this paper
• Fractional Doses of Pneumococcal Conjugate Vaccine: A Non-Inferiority Trial

  2024cites this paper
• Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance

  2024cites this paper
• Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study

  2024cites this paper
• Fractional dosing to improve vaccination coverage, vaccine hesitancy, and cost-effectiveness in Africa: a systematic review

  2023cites this paper
• Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic

  2023influential citation
• Skin-Based Vaccination: A Systematic Mapping Review of the Types of Vaccines and Methods Used and Immunity and Protection Elicited in Pigs

  2023cites this paper
• Microarray patches: scratching the surface of vaccine delivery

  2023cites this paper
• Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

  2022cites this paper
• One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh

  2022cites this paper
• Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial

  2022cites this paper
• Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey

  2022cites this paper
• Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats.

  2022cites this paper
• Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication

  2022cites this paper
• RMHP_A_309707 2079..2087

  2021cites this paper
• An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan

  2021cites this paper
• Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis.

  2021cites this paper
• Intradermal Vaccination: A Potential Tool in the Battle Against the COVID-19 Pandemic?

  2021cites this paper
• Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice

  2021cites this paper
• Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.

  2021cites this paper
• Nonpolio Enteroviruses, Polioviruses, and Human CNS Infections

  2020cites this paper
• Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects

  2020cites this paper
• Polio switch strategy: An obituary in the making?

  2020cites this paper
• Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial

  2020cites this paper
• Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial

  2020cites this paper
• Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China.

  2020cites this paper
• CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Needleless Injectors for the Administration of Vaccines: A Review of Clinical Effectiveness

  2020cites this paper
• One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine.

  2020cites this paper
• Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis

  2020cites this paper
• Polio and Its Epidemiology

  2020influential citation
• School of Nursing 4-11-2014 Cuba ’ s Maternal-Child Health

  2019cites this paper
• Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age

  2019cites this paper
• Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.

  2019influential citation
• Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists

  2019cites this paper
• Moving from oral poliovirus vaccine to inactivated poliovirus vaccine: The rationale and challenges

  2019cites this paper
• The Development of Polio Vaccines: the Current Update (Review)

  2019cites this paper
• Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine

  2019cites this paper
• Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine.

  2019cites this paper
• Intradermal Synthetic DNA Vaccination Generates Leishmania-Specific T Cells in the Skin and Protection against Leishmania major

  2019cites this paper
• Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.

  2019cites this paper
• Protocol for a systematic review and meta-analysis of fractional dose compared with standard dose inactivated polio vaccination in children

  2019cites this paper
• Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

  2019cites this paper
• Understanding the basis of transcutaneous vaccine delivery.

  2019cites this paper
• ON CURRENT POLIO VACCINES: VACCINATION SCHEDULES AND ADMINISTRATION ROUTES

  2019cites this paper
• Immunogenicity characterization of enterotoxigenic Escherichia coli (ETEC) toxoid fusion and adhesin MEFA antigens in intradermally or intramuscularly immunized mice

  2018cites this paper
• Cuba's Scientific Contributions to Global Polio Eradication.

  2018cites this paper
• Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.

  2018cites this paper
• Polio Vaccines: Present and Future

  2018cites this paper
• Experiencia cubana en inmunización, 1962–2016

  2018cites this paper
• 48 – Poliovirus Vaccine–Inactivated

  2018cites this paper
• Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial

  2017cites this paper
• Maximising the impact of inactivated polio vaccines.

  2017cites this paper
• Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial

  2017cites this paper
• Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.

  2017cites this paper
• High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses

  2017cites this paper
• Poliovirus vaccination during the endgame: insights from integrated modeling

  2017cites this paper
• Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)

  2017cites this paper
• Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan

  2017cites this paper
• Technologies to Improve Immunization

  2017cites this paper
• Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

  2017influential citation
• Feasibility of conducting intradermal vaccination campaign with inactivated poliovirus vaccine using Tropis intradermal needle free injection system, Karachi, Pakistan

  2017cites this paper
• Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.

  2016cites this paper
• Jet Injection of Viscous Fluids

  2016cites this paper
• Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses.

  2016cites this paper
• Presentation matters: Buffers, packaging, and delivery devices for new, oral enteric vaccines for infants

  2016cites this paper
• Intradermal vaccination for infants and children

  2016cites this paper
• Alternative administration routes and delivery technologies for polio vaccines

  2016cites this paper
• Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses

  2016cites this paper
• The Epidemiology of Poliomyelitis Deconstructed

  2016cites this paper
• Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy.

  2016influential citation
• Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles

  2016cites this paper
• [Seroprevalence of antibodies to measles, rubella, mumps, hepatitis B viruses and all three poliovirus serotypes among children in Quindío, Colombia].

  2016cites this paper
• The Need and Potential of Inactivated Poliovirus Vaccine.

  2016cites this paper
• The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.

  2016cites this paper
• Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats

  2016cites this paper
• Goodbye switch and Imminent Polio Victory

  2016cites this paper
• Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.

  2015cites this paper
• Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

  2015cites this paper
• sIPV process development for costs reduction.

  2015cites this paper
• Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.

  2015cites this paper
• Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.

  2015cites this paper
• Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model.

  2015cites this paper
• arly priming with inactivated poliovirus vaccine ( IPV ) and ntradermal fractional dose IPV administered by a microneedle evice : A randomized controlled trial

  2015cites this paper
• Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future

  2015cites this paper
• Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.

  2015cites this paper
• Polio vaccination: past, present and future.

  2015cites this paper
• Recent insights into cutaneous immunization: How to vaccinate via the skin.

  2015cites this paper
• CUBA'S MATERNAL-CHILD HEALTH

  2014cites this paper
• A quantitative survey of the literature on poliovirus infection and immunity.

  2014cites this paper
• Effective use of transdermal drug delivery in children.

  2014cites this paper
• Current Status and Future of Polio Vaccines and Vaccination

  2014cites this paper
• Safety of Vaccines Used for Routine Immunization in the United States.

  2014cites this paper
• Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature

  2014cites this paper
• Closing the global immunization gap: delivery of lifesaving vaccines through innovation and technology.

  2014cites this paper
• National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication

  2014cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Affordable inactivated poliovirus vaccine: strategies and progress.

  2014cites this paper
• Closing the Global Immunization Gap: Delivery of Lifesaving Vaccines Through Innovation and Technology

  2014cites this paper